BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 684225)

  • 1. [Diagnostic value of radionuclide bone imaging in monitoring skeletal metastases (author's transl)].
    Rey G; Schlegel G; Haase W
    Radiologe; 1978 Aug; 18(8):302-9. PubMed ID: 684225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone metastases from breast cancer as detected by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):449-56. PubMed ID: 693261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. I. Incidence of bone metastases from bronchogenic carcinoma and their prognosis (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Nov; 38(11):1054-63. PubMed ID: 733476
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of bone scintigraphy with 99mTc-labeled phosphate compounds. I. Metastatic bone tumor (author's transl].
    Yamamoto I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Sep; 38(9):862-78. PubMed ID: 101970
    [No Abstract]   [Full Text] [Related]  

  • 5. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
    Creutzig H
    Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Scanning of bone metastases (author's transl)].
    Robillard J
    J Radiol Electrol Med Nucl; 1977 Nov; 58(11):722-5. PubMed ID: 592250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. The ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Sep; 39(9):984-92. PubMed ID: 514803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bone scintigraphy--abnormal RI accumulation in soft tissue metastasis from osteosarcoma with 99Tc-MDP (author's transl)].
    Suzuki M; Kato T; Imaeda T; Doi H
    Rinsho Hoshasen; 1979 Jan; 24(1):171-2. PubMed ID: 283256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. II. Comparison between bone scintigraphy and roentgenographic findings and their assessments (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jun; 39(6):627-36. PubMed ID: 482079
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of various bone diseases by 99mTc-MDP (author's transl)].
    Tobari C; Fukuoka Y; Kanaumi H; Murai M; Ajima M; Kurosawa H
    Kaku Igaku; 1978 Apr; 15(2):267-74. PubMed ID: 671868
    [No Abstract]   [Full Text] [Related]  

  • 11. [99mTc-methylene diphosphonate for skeletal imaging (author's transl)].
    Yatomi K; Nakasikiryo K; Okada R; Ogasawara M; Nakagawa T; Nakagawa K; Kinoshita F
    Radioisotopes; 1977 Nov; 26(11):810-2. PubMed ID: 202999
    [No Abstract]   [Full Text] [Related]  

  • 12. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant lymphoma and the skeleton (author's transl)].
    Konopásek B; Hermanský F; Kolár J; Bek V; Bednár B; Stĕpán J
    Sb Lek; 1980; 82(4):107-10. PubMed ID: 7384735
    [No Abstract]   [Full Text] [Related]  

  • 14. [X-ray survey and radioisotope scanning of the skeleton in the evaluation of bone metastases in prostatic carcinoma].
    Meiraz D; Garti I; Lubin E
    Harefuah; 1978 Nov; 95(10):332-3. PubMed ID: 570535
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative whole-body bone scintigraphy. III. Clinical significance for the diagnosis of bone metastases, systemic bone diseases and diseases of the joint (author's transl)].
    Anger K; Küper K
    Nuklearmedizin; 1980 Jul; 19(3):108-19. PubMed ID: 7465430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of metastatic bone tumors by radionuclide imaging (author's transl)].
    Uchiyama G; Uno K; Umeda T; Nagase J
    Rinsho Hoshasen; 1979 Jul; 24(7):747-54. PubMed ID: 480669
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tc99m pyrophosphate scintigraphy compared to conventional X-ray studies in the diagnosis of bone metastasis (author's transl)].
    Claure H; Olea E; Schiappacasse V; Reginato AJ; Martínez C
    Rev Med Chil; 1978 Jul; 106(7):515-7. PubMed ID: 694276
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations of bone scanning in clinical oncology.
    Loeffler RK; DiSimone RN; Howland WJ
    JAMA; 1975 Dec; 234(12):1228-32. PubMed ID: 1242747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of 99mTc-methylene diphosphonate (MDP) as bone imaging agent (author's transl)].
    Senda K; Imaeda T; Kato T; Asada S; Doi H
    Rinsho Hoshasen; 1978 Sep; 23(9):937-42. PubMed ID: 691805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone scintigraphy: diagnostic value and indications (author's transl)].
    Gaucher A; Colomb JN; Naoun A
    Nouv Presse Med; 1981 Jan; 10(4):239-42. PubMed ID: 7465360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.